Detection of TP53/PIK3CA Mutations in Cell-Free Plasma DNA From Metastatic Breast Cancer Patients Using Next Generation Sequencing

30Citations
Citations of this article
70Readers
Mendeley users who have this article in their library.
Get full text

Abstract

We performed whole exon sequencing of TP53 and PIK3CA genes from the plasma DNA of 17 metastatic breast cancer patients using next generation sequencing. We identified 13 mutations, 7 of which were acquired mutations. Patients with TP53 or PIK3CA mutations in plasma DNA had a significantly (P

Cite

CITATION STYLE

APA

Nakauchi, C., Kagara, N., Shimazu, K., Shimomura, A., Naoi, Y., Shimoda, M., … Noguchi, S. (2016). Detection of TP53/PIK3CA Mutations in Cell-Free Plasma DNA From Metastatic Breast Cancer Patients Using Next Generation Sequencing. Clinical Breast Cancer, 16(5), 418–423. https://doi.org/10.1016/j.clbc.2016.05.004

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free